Search - tctmd.com

Displaying 21 - 40 of 218

Sort: Relevancy | Date

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Presentation TCT 2018

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Presenter: Felix Mahfoud, Patrick W. Serruys, Gregg W. Stone

September 25, 2018

Presentation TCT 2018

Falcon Development and Status

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Richard J. Rapoza

September 22, 2018

Presentation TCT 2018

How to Improve BRS Outcomes: Focus on Imaging and Technique

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Ziad A. Ali

September 22, 2018

Presentation TCT 2018

How to Improve BRS Outcomes: Focus on the Device

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Yoshinobu Onuma

September 22, 2018

Presentation TCT 2018

ABSORB 4-Year Meta-Analysis: Individual Patient-Data Analysis

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Gregg W. Stone

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Dean J. Kereiakes

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB China 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Runlin Gao

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Kengo Tanabe

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Patrick W. Serruys

September 22, 2018

Presentation TCT 2018

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Antonio L. Bartorelli, David G. Rizik, Michael Haude

September 21, 2018

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes

September 21, 2018

Presentation TCT 2018

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Patrick W. Serruys

September 21, 2018

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

Presentation ESC 2018

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Presenter: Holger M. Nef

August 29, 2018

Presentation JIM 2018

New Fully Absorbable Patch Based Large Hole Vascular Closure Device

Presenter: Michael Laule

February 23, 2018

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

Presenter: Martin B. Leon, Marco Valgimigli, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Gregg W. Stone

November 01, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Presenter: Bernard R. Chevalier, Corrado Tamburino, Yoshinobu Onuma

October 31, 2017

Advertisement

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Falcon Development and Status

How to Improve BRS Outcomes: Focus on Imaging and Technique

How to Improve BRS Outcomes: Focus on the Device

ABSORB 4-Year Meta-Analysis: Individual Patient-Data Analysis

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

ABSORB Beyond 3 Years: ABSORB China 4-Year Data

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

New Fully Absorbable Patch Based Large Hole Vascular Closure Device

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content